Skip to main navigation Skip to search Skip to main content

Monoclonal antibody therapy in cancer: When two is better (and considerably more expensive) than one

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Monoclonal antibody therapy in cancer: When two is better (and considerably more expensive) than one'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science